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Abstract: 3-Methylcholanthrene (MCA) is a polycyclic aromatic hydrocarbon and potent carcinogenic agent that is often used in
experimental cancer studies. Butylated hydroxytoluene (BHT) has been widely used for many years as an antioxidant to preserve and
stabilize the freshness, nutritional value, flavor, and color of foods. The aim of the present study was to investigate the role of the
application of MCA and BHT in the development of lung cancer, and to detect any mutation in the Ki-ras gene exon 2. Rats were
killed by cervical dislocation 26 weeks after the last BHT injection and lung tissues were surgically removed. Lung tissues of the
control and experiment rat groups were examined for point mutations in the exon 2 of the Ki-ras by PCR based SSCP analysis. No
point mutation was observed in the Ki-ras gene exon 2.
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3-Metilkolantren ve Bütil Hidroksitoluenle Uyarılmış Rat Akciğer Dokularında
Ki-ras Ekson 2 Geni Mutasyon Analizi
Özet: Bir polisiklik aromatik hidrokarbon ve potansiyel karsinojenik ajan olan MCA, deneysel kanser çalışmalarında sıklıkla kullanılır.
BHT, yiyeceklerin tazeliğini, besin değerini, tadını ve rengini sabit tutmak ve korumak için, antioksidan olarak yıllardan beri yaygın
olarak kullanılmaktadır. Bu çalışmanın amacı akciğer kanser gelişiminde, MCA ve BHT’nin rolünü araştırmak; Ki-ras ekson 2 geninde
herhangi bir mutasyona neden olup olmadığını tespit etmektir. Ratlar son enjeksiyondan 26 hafta sonra servikal dislokasyon ile
öldürüldü ve akciğer dokuları çıkarıldı. Kontrol ve deney grubu ratların akciğer dokuları Ki-ras ekson 2 geni nokta mutasyonları için
PCR tabanlı SSCP analiziyle incelendi. Sonuç olarak Ki-ras ekson 2 geninde hiçbir nokta mutasyonu görülmedi.
Anahtar Sözcükler: Ki-ras geni, 3-metilkolantren, bütil hidroksitoluen, rat akciğer dokusu, mutasyon

Introduction
3-Methylcholanthrene (MCA) is a polycyclic aromatic
hydrocarbon (PAH) that is widely reported in polluted
urban air. It is also a potential carcinogenic agent that is
often used in experimental cancer studies. Butylated
hydroxytoluene (BHT) has been widely used for many
years as an antioxidant to preserve and stabilize the
freshness, nutritional value, flavor, and color of foods and
animal feed products. In some recent studies, it has been
claimed that these agents may cause cancers in the human
liver, lungs, colon, breast, stomach, and urinary tract
(1,2).

PAHs are generally known as potential carcinogens.
They constitute the active ingredient of the tar fraction of
cigarette smoke, charbroiled foods, and atmospheric
pollution. PAHs cross the placental membrane to induce
fetal cytochrome P450 metabolizing enzymes (1,2). The
formation of PAHs is related to the incomplete
combustion of solid and fuel oils. For this reason, in daily
life, heating systems and vehicle emissions are the most
common sources of exposure to PAH. These sources are
the most significant causes of air pollution in most cities
(2,3). It is thought that 10% of cancer cases related to
the respiratory system result from air pollution.
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Additionally, there are some reports of an increased
incidence of leukemia in some populations that are
exposed to these substances (4).
Synthetic phenolic antioxidants are added to foods in
order to retard the auto-oxidation of lipids. BHT is one of
the major antioxidants and has been widely used in foods
all over the world (5). BHT has played a role as a typical
promoting agent for tumorogenesis in biological systems
(6). Although BHT itself is not genotoxic or carcinogenic,
it may modulate tumor formation in mice lung
tumorogenesis within the concept of 2-stage
carcinogenesis (7). In mice, BHT can prevent or promote
lung tumor formation, depending on the inbred strain and
age. The effect of BHT also depends on whether BHT is
administered before or after carcinogen exposure. Tumor
promotion by BHT application in rodents is achieved by
repeated administration of this agent on a weekly basis
after a single carcinogen exposure (8).
Coded protein products of proto-oncogenes generally
have an important role in the regulation of cell
signalization and cell growth. By being activated by
mutation, chromosomal translocation, amplification, or
transcriptional dysregulation, these genes cause abnormal
protein synthesis or excessive protein production. The
activated proto-oncogenes are called oncogenes while
protein products are called oncoproteins.
The Ras family is composed of H-ras, Ki-ras, and Nras. Ras proteins exhibit guanosine triphosphatase
(GTPase) activity in the membrane and have a role in
signal transduction from cell membrane to the nucleus
and in cell growth. Since mutant Ras protein inhibits
GTPase activity, the production of gene products turns
into an uncontrolled process. In various tumors, including
breast, lung, and colon cancer, amino acid substitutions
were detected in Ras protein especially in the 12th, 13th,
and 61st positions (9-11). In addition, according to
Watanabe et al., Ki-ras is a very important gene for
development in mice; mice, which do not carry this gene
as a homozygote, are reported to have died on the 12th
to 14th day of pregnancy (12). In a study carried out on
mice using MCA, it was reported that there was an
increase in transversion-type mutations in Ki-ras
oncogenes in lung tumors and that these mutations
occurred at a very early phase (13).
The purpose of the current study was to determine,
experimentally, the combined mutagenic effects of MCA
and BHT on the lung tissues of rats.
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Materials and Methods
Animals
All procedures were approved and performed under
the guidelines of the Animal Ethics Committee of the
School of Medicine, Cumhuriyet University. Fifty nontransgenic adult male rats (Wistar albino strain), weighing
100 to 110 g, were received at 8 weeks of age and
allowed 1 week for adjustment to their new environment.
The rats were kept in optimal laboratory conditions, fed
with standard rat food, and given tap water ad libitum.
They were randomized into 1 control and 3 experimental
agent administration groups. The rats were first injected
with individual agents, and then together in various dose
combinations. After 26 weeks of injection, the control and
experimental group rats were killed by cervical dislocation
and the lung tissues were used for genomic DNA isolation.
The genotyping of the proto-oncogene Ki-ras exon 2 gene
domain was performed using PCR based SSCP and direct
sequencing techniques.
Experimental Design
The rats were exposed to potential carcinogens of
MCA (as a cancer initiator) and BHT (as a progressive
agent) in tissue tumorogenesis in the rat model. MCA
(Aldrich-Chem) and BHT (Sigma –B1378) were dissolved
in corn oil. Rats from the first experiment group received
an intraperitoneal injection of 40 mg MCA per kilogram
of body weight once a week (Group I, 15 male rats), 200
mg BHT per kilogram of body weight was administered
after a single dose of MCA once a week to the second
group (Group II, 14 male rats, dual agent administered
group), and 200 mg of BHT per kilogram of body weight
was administered to the third group once a week (Group
III, 12 male rats). Control group animals were injected
with corn oil (Group IV, 9 male rats of sham group that
had been transferred to the laboratory under the same
handling stresses as the treated rats). All administrations
to the experiment groups were carried out in 6-week
periods. Following 26 weeks of the experimental period,
all rat groups were killed by cervical dislocation and lung
tissues were surgically removed.
Isolation of Genomic DNA
Lung tissues of the animals in the control and
experimental groups were taken and genomic DNA was
isolated from the fresh tissues according to the basic DNA
extraction method modified by Ozdemir et al. Briefly, the
control and experimental rat tissues were digested with
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proteinase K (25 μl of 10 mg/ml), the genomic DNA was
extracted with PCI (phenol, chloroform, and isoamyl
alcohol, at a ratio of 25:24:1 respectively), and DNA was
precipitated with cold ethanol (14).
PCR Amplification
Lyophilized primers (MWG-Biotech CimbH Paris,
France) were used to amplify the exon 2 of Ki-ras
oncogene 170-bp amplicons, respectively (Ki-S, 5’-CTC
CTA CAG GAA ACA AGT AG-3’; Ki-AS, 5’-GGT GAA TAT
CTT CAA ATG ATT-3’). The thermocycling procedure
consisted of 50 μl reaction mixtures containing 200 μM
dNTPs (MBI, Fermentas), 0.5 μM primers, 30 ng
template DNA, 2 μl Taq DNA polymerase buffer, 0.1 μl (5
U/μl) Taq DNA polymerase (Boehringer, Mannheim), and
38.8 μl distilled water in an Amplitron I DNA Thermal
Cycler (Thermolyne) under the following conditions:
initial template denaturation was programmed for 30´´ at
96 °C and the cycle procedure was 30´´ at 58 °C for
annealing and 30´´ at 72 °C for extension. Thirty-five
cycles per sample were performed.

and some of experimental group rats, lung tissues were
normal in appearance and were a homogeneous pink color
and crepitation was recorded in macroscopic and
microscopic examinations. Alveoli, bronchia, and vessels
were also normal in appearance histopathologically. Nonspecific changes such as alveolar bleeding, a few
inflammatory cells that were formed by lymphocytes
around bronchial and interstitial area, and atelectasia
were seen in tissue examinations of the experimental
group rats. Tumoral developments were observed in 5
rats of the chronic MCA injected group. Those
subcutaneous malignant mesenchymal tumors were 4 × 4
cm in diameter and localized at the injection sites.
Fusiform cell proliferation and multinuclear tumoral giant
cells were also detected at the injection site of the chronic
MCA group rats after histopathologic examination (Figure
1). Immunohistochemically, desmin and vimentin were
stained positively in those soft, malign tumoral tissue
cells.

Genotyping
PCR products of the exon 2 of the Ki-ras were used
for SSCP analysis. Five microliters of denaturing loading
buffer (95% formamide, 100 mM NaOH, 0.25%
bromophenol blue, 0.25% xylencyanol) were added to 5
μl of amplification product. Samples were denatured at
95 ºC for 10 min and placed on ice for 10 min.
Electrophoresis was carried out using a 10% vertical
nondenaturing polyacrylamide gel (37.5-1, acrylamide to
bis-acrylamide cross-linking) in the TBE buffer (0.089 M
tris, 0.089 M boric acid, 0.001 M disodium EDTA)
(Sigma). The mixture was loaded on to the gel and
processed at 60 mA for 24 h. Using an ABI 310 DNA
sequencer (Iontek Limited, İstanbul, Turkey) DNA
sequencing analysis was performed on the samples that
were suspected to have mutation.

Results
During the 26-week application period, 6 rats from
the MCA group and 1 rat from each of the other
“combined agent” groups were recorded. Gross tumor
development was not observed in either the control group
rats or in members of the experimental groups. There
was also no change in tissue based on radiological and
scintigraphic examinations. Regarding control group rats

Figure 1. Malign soft tissue tumor with atypical fusiform cells, giant
tumoral cells (H&E 25).
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In the single strand conformational polymorphism
analysis, the combined MCA/BHT applied gene domain
showed a mutated profile that was not observed in the
control or the other chronic MCA group rats (Figure 2).
These suspected samples were identified by direct
sequencing for the detection of possible point mutation
and were compared to the control group rats. No point
mutation was detected in the whole sequential gene
domain that belonged to the control or experimental
group rats (Figure 3).

(17). BHT can increase the stability of pharmaceuticals,
fat-soluble vitamins, and cosmetics. The lifespan of
rubber, elastomers, and plastics is increased via adding
BHT (18). BHT, a-tocopherol, propyl gallate, and tbutylhydroquinone are all used as antioxidants
throughout the world. These antioxidants modify the first
or second stage of 2-step chemical carcinogenesis in
various organs in rodents (6).
In this study we injected 40 mg/kg MCA and 200
mg/kg BHT both separately and in combination to the rat
groups. After the injection period, PCR, SSCP, and DNA
sequencing analysis techniques were applied to the DNA
isolated from the stimulated lungs. The Ki-ras gene exon
2 domain was scanned for possible mutations.

Discussion
PAHs are among the most common environmental
pollutants and are toxic substances that cause
carcinogenesis, teratogenesis, and dysfunction of the
immune system (15,16). MCA, which is also included in
this group, has been used as a cancer inductive and
stimulating agent in liver enzymes (17).

In our study PCR/SSCP analyses were performed on
Ki-ras exon 2 gene in rat lung tissues that were
stimulated with 40 mg/kg MCA and were promoted with
repetitive 200 mg/kg BHT doses (Figure 2). As a result of
the PCR/SSCP analysis, an extra band in which mutation
was thought to have occurred was detected in 3 rat lung
tissues in the MCA+BHT group (Figure 3). PCR was re-

BHT, an antioxidant used as a promoting agent in
carcinogenesis studies, has been used as an additive in
various food substances in quantities of 25-400 mg/kg







 













 












Figure 2. SSCP profiles belonging to the control and experimental group rat lung tissues that
treated with MCA and BHT. ss: single strand, ds: double strand.
Lanes
Lane 1: Single and double strands (170 bp) DNA of normal appearance in control rat.
M:Marker, DNA ladder 100 bp.
Lanes 2–7: Non-denaturated (line 2) and denaturated PCR products from both MCA and
BHT treated experimental group lung tissues. Arrow indicates mutated single strand in
one rat (line 6).
Lanes 8–14: Denaturated products from only BHT treated experimental group rat tissues.
No mutation was detected.
Lanes 15–19: Denaturated products from only MCA treated experimental group rat
tissues. No mutation was detected.
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Figure 3. In a group to which MCA-BHT applied, SSCP images belonging
to the samples carrying suspected mutation (Lanes 1-3) and
control (C).

applied to those tissues thought to be mutant with the
purpose of determining the possible point mutation type
and localization; DNA sequence analyses were performed
and compared with the wild type. As a result of the
forward and reverse DNA sequence analysis, it was
observed that the sequence of these samples matched that
of control group samples and thus they were not
mutations. As indicated in Figure 3, it is thought that this
extra band in SSCP profiles of the samples may have
appeared as a result of a possible contamination during
PCR, a non-specific amplification, or a possible error
caused by the present laboratory conditions or the
polyacrylamide gel prepared during SSCP. The SSCP
method has many advantages, including simplicity and a
modest requirement in terms of laboratory equipment.
However, various factors such as ionic strength,
temperature, gel concentration, polymerization, glycerol
amount, and tampon concentration affect the results
obtained in polyacrylamide gel electrophoresis (19,20).
In the present study, no tumor formation was found
and no mutation occurred in the pathological evaluation
performed on lungs of the chronic BHT group. This may
be because this substance is only a promoter in tumor
formation or because the rats are resistant to (or
developed a tolerance to) this substance. According to the
studies conducted, when applied alone, BHT cannot form
a tumor in mice; however, it causes severe pulmonary
inflammation. Although BHT activates its tumor
developing effect by blocking cellular communication
channels when applied at high doses, it cannot form a
tumor by activating such an effect when administered

alone (21). According to a study in which mice were
repeatedly injected with BHT, only the first injection
increased cell proliferation in the lung. After 2 or more
injections no increase occurred in DNA synthesis. In their
studies on A/J mice, Witschi and Morse confirmed that the
mice developed a tolerance to repetitive BHT injections
(22).
In a study conducted with Fisher 334 BigBlue® rats,
MCA (80 mg/kg bw) was injected intraperitoneally, and it
was found that transversion-type mutations developed in
the Ki-ras oncogene in the lungs of the rats (13). Another
experimental group in our study was injected
intraperitoneally with 40 mg/kg MCA once a week for 6
weeks. In the pathologic examinations performed at the
end of the experiment period, no tumor formation was
detected, either at macroscopic or microscopic level, in
the lungs. However, in 5 of 9 rats in this group only, a
malign soft tissue tumor of mesenchymal origin weighing
approximately 100-130 g was detected in the groin area.
In the light of these findings, it can be stated that MCA is
not only a cancer-inducing agent in the formation of soft
tissue tumors, but can also be a promoter. However, the
results of the SSCP conducted on both lung tissue and
soft tissue tumors of this group showed no mutation in
the Ki-ras exon 2 gene domain. In the studies conducted
by Wessner et al. on pregnant rats using MCA, rats were
killed with cervical dislocation 12 months after they were
born and it was found that various tumors occurred in the
lung and liver. They found that while Ki-ras mutations
occurred in some of these tumors, in some of the tumors
no mutation occurred in this gene (23).
In a study conducted by Witschi and Morse, one dose
of MCA at a rate of 10 mg/kg was injected
intraperitoneally into AJ mice. Observations made 2, 3,
and 4 weeks after the injection showed that they were
unsuccessful in producing cell hyperplasia in the lungs.
They therefore concluded that MCA used at this dosage
will influence the stimulation of lung tumors in mice. The
same researchers injected AJ mice with 10 mg/kg MCA
once a week for 6 weeks followed up with a 300 mg/kg
BHT injection once a week for 5 weeks repeatedly. After
4 months, an increase was found in the number of
tumors. They argued that BHT should be administered
over a certain dosage that completely causes cell
hyperplasia in the lungs; only under such a condition can
BHT be effective as a tumor proliferator (22).
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In conclusion, BHT, which is an antioxidant substance
used in carcinogenesis studies, cannot form tumors in rats
when injected alone and chronically. In our study, no
tumors were formed in the lungs of the chronic MCA
group; however, soft tissue tumors occurred in the groin
area of 5 out of 9 rats. Another group was injected with
a single dose of 40 mg/kg MCA and then 200 mg/kg of
BHT once a week for 6 weeks. In this group, no tumor
formation occurred in the lungs and no mutation was
encountered in the Ki-ras exon 2 gene. In 2-stage
carcinogenesis studies carried out on rats, we suggest
that MCA, which is used as the inducing agent, and BHT,
which is used as the promoting agent, should be injected
at higher doses.
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